|
Mechanism4HPPD inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date18 Jan 2002 |
100 Clinical Results associated with MendeliKABS Inc.
0 Patents (Medical) associated with MendeliKABS Inc.
100 Deals associated with MendeliKABS Inc.
100 Translational Medicine associated with MendeliKABS Inc.